Chakma Justin

CIK 00019512381 companySAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001951238

Recent Transactions

42 trades

Award
ARS Pharmaceuticals, Inc.$SPRY
Stock option (right to buy)
2026-01-02+240,000→ 240,000 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2025-11-12$0.84/sh+30,000→ 166,380 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2025-11-12$8.91/sh−30,000→ 136,380 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (Right to Buy)
2025-11-12−30,000→ 89,047 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2025-11-12$8.86/sh−136,380→ 0 total
Award
ARS Pharmaceuticals, Inc.$SPRY
Stock option (right to buy)
2025-01-02+274,100→ 274,100 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-12-13$12.06/sh−27,272→ 136,380 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (Right to Buy)
2024-12-13−27,272→ 55,461 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-12-13$1.44/sh+27,272→ 163,652 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-12-12$0.84/sh+117,333→ 253,713 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (Right to Buy)
2024-12-12−117,333→ 119,047 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-12-12$12.27/sh−117,333→ 136,380 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (Right to Buy)
2024-12-10−50,000→ 0 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-12-10$13.15/sh−50,000→ 136,380 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-12-10$0.84/sh+50,000→ 186,380 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (Right to Buy)
2024-12-06−50,000→ 50,000 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-12-06$14.23/sh−50,000→ 136,380 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-12-06$0.84/sh+50,000→ 186,380 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-12-05$14.13/sh−49,640→ 136,380 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-12-05$0.84/sh+49,640→ 186,020 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (Right to Buy)
2024-12-05−49,640→ 100,000 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (Right to Buy)
2024-12-04−45,000→ 149,640 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-12-04$0.84/sh+45,000→ 181,380 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-12-04$13.95/sh−45,000→ 136,380 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-12-03$0.84/sh+41,740→ 181,380 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (Right to Buy)
2024-12-03−3,260→ 0 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (Right to Buy)
2024-12-03−41,740→ 194,640 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-12-03$13.19/sh−45,000→ 136,380 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-12-03$0.84/sh+3,260→ 139,640 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Stock Option (Right to Buy)
2024-12-02−45,000→ 3,260 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-12-02$13.67/sh−45,000→ 136,380 total
Exercise/Conversion
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-12-02$0.84/sh+45,000→ 181,380 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-11-27$14.39/sh−25,000→ 136,380 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-11-26$14.05/sh−42,186→ 161,380 total
Sale
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2024-11-25$14.00/sh−32,814→ 203,566 total
Award
ARS Pharmaceuticals, Inc.$SPRY
Stock option (right to buy)
2024-01-02+350,000→ 350,000 total
Award
ARS Pharmaceuticals, Inc.$SPRY
Stock option (right to buy)
2023-01-03+165,000→ 165,000 total
Award
ARS Pharmaceuticals, Inc.$SPRY
Stock option (right to buy)
2022-11-08+236,380→ 236,380 total
Award
ARS Pharmaceuticals, Inc.$SPRY
Stock option (right to buy)
2022-11-08+236,380→ 236,380 total
Award
ARS Pharmaceuticals, Inc.$SPRY
Stock option (right to buy)
2022-11-08+82,733→ 82,733 total
Award
ARS Pharmaceuticals, Inc.$SPRY
Common Stock
2022-11-08+236,380→ 236,380 total
Award
ARS Pharmaceuticals, Inc.$SPRY
Stock option (right to buy)
2022-11-08+48,260→ 48,260 total

Companies

ARS Pharmaceuticals, Inc.
Chief Business Officer
$SPRY

Recent Filings

Address

C/O ARS PHARMACEUTICALS, INC. 11682 EL CAMINO REAL, SUITE 300

SAN DIEGO, CA, 92130

View on SEC.gov